(Q57338554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Age, obesity and inflammation at baseline predict the effects of testosterone administration on the metabolic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

0 references

1 reference

1 reference

1 reference

Farid Saad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ahmad Haider

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

Hormone Molecular Biology and Clinical Investigation

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

193-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

The decline of androgen levels in elderly men and its clinical and therapeutic implications

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Androgen deficiency, diabetes, and the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Effects of androgen therapy on adipose tissue and metabolism in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Blood testosterone threshold for androgen deficiency symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

The CAG repeat polymorphism within the androgen receptor gene and maleness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Role of adipose tissue as an inflammatory organ in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Getting the message across: mechanisms of physiological cross talk by adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Inflammatory markers and cardiovascular health in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

Pharmacogenetics of testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI.2010.081

21 January 2018

Identifiers

DOI

10.1515/HMBCI.2010.081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25961255%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference